Alexandra K. Kiemer
Saarbruecken, SL 66123, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
HyperTRIBE identifies hepatic IGF2BP2/IMP2 targets in vivo and links IMP2 to autophagy.
Journal: NAR molecular medicine
Published: March 19, 2026
Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2/IMP2).
Journal: European journal of medicinal chemistry
Published: November 14, 2025
Extracellular vesicles derived from Enterococcus faecalis: inflammatory activation does not require internalization.
Journal: Cell communication and signaling : CCS
Published: September 19, 2025
IGF2BP2 Deficiency in Macrophages Impairs Migration, Reprograms Metabolism, and Limits Tumor Progression.
Journal: International journal of biological sciences
Published: July 21, 2025
Biodynamers as prodrugs with controlled uptake and activity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 30, 2025
Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner.
Journal: International journal of cancer
Published: April 29, 2025
Laminar Flow Alters EV Composition in HUVECs: A Study of Culture Medium Optimization and Molecular Profiling of Vesicle Cargo.
Journal: Small methods
Published: October 30, 2024
Immunomodulation by glucocorticoid-induced leucine zipper in macrophages: enhanced phagocytosis, protection from pyroptosis, and altered mitochondrial function.
Journal: Frontiers in immunology
Published: March 06, 2024
Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 24, 2023
Last Updated: 09/26/2026